BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Business

  Capricor Therapeutics to Present First Quarter 2022 Financial Results and Recent Corporate Update on May 10Company to Host Conference Call, May 10, 2022, at 4:30 p.m. ET

  Capricor Therapeutics will release its financial results for the first quarter ended March 31, 2022, after the market close on Tuesday, May 10, 2022.

  May 3, 2022

   · 

  3 min read
• Biotech Bay

  Vaxcyte to Participate in Upcoming Investor Conferences in May 2022

  Vaxcyte, Inc. announced that Company management will participate in and host one-on-one meetings at the following investor conferences.

  May 3, 2022

   · 

  2 min read
• Business

  ABVC BioPharma Enters Into $3.0 Million Clinical Services Contract with NeuCen BioMed

  ABVC Biopharma, Inc. today announced that BioKey, a wholly-owned subsidiary of the company based in Fremont, California, has entered into a $3.0 million clinical services contract with NeuCen BioMed Co. Ltd.

  May 3, 2022

   · 

  3 min read
• Business

  Evoke Pharma to Report First Quarter 2022 Financial Results on May 10, 2022

  Evoke Pharma, Inc. today announced that the Company is scheduled to release its first quarter 2022 financial results on Tuesday, May 10, 2022, after the market closes.

  May 3, 2022

   · 

  3 min read
• TC BioPharm Invited to Present at LD Micro Conference

  TC Biopharm (Holdings) PLC announced today that the company will participate at the upcoming 2022 LD Micro Invitational Conference.

  May 3, 2022

   · 

  2 min read
• New study validates predictive biomarkers in diabetic kidney disease, an important step in precision medicine.

  Journey Biosciences, Inc. A new study recently published in the journal Diabetes Care continues to validate the role that specific biomarkers - advanced glycation endproducts (AGEs) - in predicting if a person with diabetes will develop kidney disease.

  May 3, 2022

   · 

  2 min read
• Biotech Bay

  R2 Technologies’s GLACIAL®Rx Clinical Data Presented at the Annual Meeting of the American Society for Laser Medicine and Surgery (ASLMS)

  R2 Technologies Inc. today announced that data related to GLACIAL ® Rx, the first-to-market controlled cooling platform of its kind, was presented during the annual meeting of the American Society for Laser Medicine and Surgery (ASLMS) which took place from April 27-30.

  May 3, 2022

   · 

  2 min read
• Pharm Country

  AmerisourceBergen & Biopharmaceutical Companies Discuss Strategies to Advance Pharmaceutical Innovation and Access at ThinkLive Commercialization Conference

  AmerisourceBergen & Biopharmaceutical Companies Discuss Strategies to Advance Pharmaceutical Innovation and Access at ThinkLive Commercialization Conference.

  May 3, 2022

   · 

  4 min read
• Business

  Quanterix Corporation to Release First Quarter 2022 Financial Results on May 10, 2022

  Quanterix Corporation today announced that it will release its financial results for first quarter 2022 before the start of trading on May 10, 2022.

  May 3, 2022

   · 

  3 min read
• Bio NC

  Xilis Participates in €325MM Oncode-PACT Consortium to Accelerate the Development of Cancer Drugs

  Xilis, Inc. announced that it is participating in the recently announced public-private Oncode-PACT.

  May 3, 2022

   · 

  4 min read